Libido News and Research

RSS

Libido in its common usage means sexual desire; however, more technical definitions, such as those found in the work of Carl Jung, are more general, referring to libido as the free creative—or psychic—energy an individual has to put toward personal development or individuation.

Study determines 115 long COVID symptoms and their associated risk factors

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms.

17 Feb 2022

How does SARS-CoV-2 infection impact female fertility?

In a recent study published in the journal International Journal of Environmental Research and Public Health, a team of researchers reviewed published literature that assessed the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female reproductive health.

19 Jan 2022

Genetic biomarker test predicts how men with high-risk prostate cancer will respond to treatment

A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.

25 Oct 2021

UH researcher set to explore how testosterone works in the brain

Most people have some idea about the hormone testosterone –how it regulates male behavior or how too little of it might cause a decrease in libido and too much might cause aggressive and irritable behavior. Turns out, no one yet knows how testosterone really does all that.

16 Aug 2021

Study assesses the prevalence of psychiatric symptoms before and during the COVID-19 pandemic

The COVID-19 pandemic and the situations of stress and sadness associated with it have not significantly increased the prevalence of depression and anxiety among participants in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil) who live in the city of São Paulo.

13 Jul 2021

Study reveals prevalence of multimorbidity among people using methamphetamine

People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.

3 Jun 2021

Methamphetamine users more susceptible to have medical, mental, and substance use issues

People who use methamphetamine are nearly twice as likely to have medical multimorbidity, and over three times as likely to have a mental illness.

2 Jun 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

Pro-inflammatory diet may be associated with increased risk of testosterone deficiency in men

Consuming a diet high in pro-inflammatory foods - including foods that contain refined carbohydrates and sugar as well as polyunsaturated fats - may be associated with increased odds of developing testosterone deficiency among men, suggests a study in The Journal of Urology, Official Journal of the American Urological Association.

21 Apr 2021

Syphilis cases in California drive a record-setting year for STDs nationwide

In certain circles of San Francisco, a case of syphilis can be as common and casual as the flu, to the point where Billy Lemon can't even remember how many times he's had it.

13 Apr 2021

Researchers find no evidence to suggest a link between beta blockers and depression

Drugs such as beta-adrenergic antagonists (beta blockers) have been linked to a range of adverse effects, including depression.

15 Mar 2021

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.

11 Feb 2021

Libido News and Research

Further Reading

Study determines 115 long COVID symptoms and their associated risk factors

How does SARS-CoV-2 infection impact female fertility?

Genetic biomarker test predicts how men with high-risk prostate cancer will respond to treatment

UH researcher set to explore how testosterone works in the brain

Study assesses the prevalence of psychiatric symptoms before and during the COVID-19 pandemic

Study reveals prevalence of multimorbidity among people using methamphetamine

Methamphetamine users more susceptible to have medical, mental, and substance use issues

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

Pro-inflammatory diet may be associated with increased risk of testosterone deficiency in men

Syphilis cases in California drive a record-setting year for STDs nationwide

Researchers find no evidence to suggest a link between beta blockers and depression

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

Study: Menopause symptoms are worse for women with premature ovarian insufficiency

Study identifies determinants that affect woman's risk of sexual dysfunction

Landmark heart study reveals new insights about risk factors for depression

Chronic sleep disruption can lead to depression in adolescents, study shows

COVID-19 may deteriorate men's testosterone levels, new data suggests

Study identifies factors that influence women's decisions regarding therapy options

Depression is prevalent during menopause, confirms study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News